Professor and Chairman, Department of Orthopaedic Surgery Chief, Orthopaedic Arthritis Service
Orthopaedic Surgery
Dr. Louis M. Kwong, MD
|
|
Give Review
Dr. Louis M. Kwong works in the field of Orthopaedic Surgery. He went to medical school at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is one of the top medical schools in the US. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. He received 2 awards: "Fellow (FACS)" and "Super Doctor". Louis Kwong has written publications. He has 37 publications published with PubMed. The lastest publication is: 'Autopsy studies of the bone-cement interface in well-fixed cemented total hip arthroplasties.' Louis Kwong is registered with Medicare and accepts Medicare payments.
Publications
- Cementless total Knee replacement fixation: a contemporary durable solution--affirms.
- Rivaroxaban, an oral, direct factor Xa inhibitor: a new option for thromboprophylaxis.
- Drug interactions with rivaroxaban following total Joint replacement surgery.
- Prevention of venous thromboembolism after hip or Knee arthroplasty: findings from a 2008 survey of US orthopedic surgeons.
- Thromboprophylaxis, bleeding and post-operative prosthetic joint infection in total hip and Knee arthroplasty: a comprehensive literature review.
- Cost-effectiveness of rivaroxaban after total hip or total Knee arthroplasty.
- Analysis of venous thromboprophylaxis duration and outcomes in orthopedic patients.
- Never events and related quality measures following total hip and total Knee replacement.
- Decreased venous thromboembolism with injectable vs oral anticoagulation after Discharge for major orthopedic surgery.
- Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis.
- Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgery.
- Deep vein thrombosis prophylaxis: better living through chemistry--in the affirmative.
- Hip Fracture and venous thromboembolism in the elderly.
- Balancing new technology with established techniques.
- A modular distal fixation option for proximal bone loss in revision total hip arthroplasty: a 2- to 6-year follow-up study.
- Thromboprophylaxis dosing: the relationship between timing of first administration, efficacy, and safety.
- Selective factor Xa inhibitors: practical guidelines for use.
- Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after Knee or hip replacement surgery: focus on rivaroxaban.
- Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and Knee replacement surgery: a review of clinical trial data.
- Rivaroxaban versus enoxaparin for thromboprophylaxis after total Knee arthroplasty (RECORD4): a randomised trial.
- Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery.
- Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
- Autopsy studies of the bone-cement interface in well-fixed cemented total hip arthroplasties.
- BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total Knee replacement. A phase II dose-ranging study.
- Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total Knee replacement surgery.
- Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total Knee replacement surgery.
- Major Joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use.
- Cost effectiveness of rivaroxaban versus enoxaparin for prevention of post-surgical venous thromboembolism from a U.S. payer''s perspective.
- Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer''s perspective.
- A quantitative in vitro assessment of fit and screw fixation on the stability of a cementless hemispherical acetabular component.
- Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip Fracture surgery.
- High failure rate of bulk femoral head allografts in total hip acetabular reconstructions at 10 years.
- The mechanism of loosening of cemented acetabular components in total hip arthroplasty. Analysis of specimens retrieved at autopsy.
- Postocclusive transcutaneous oximetry in followup assessment of tibial nonunion and healed tibia Fractures.
- Shielding of the patient's gonads during intramedullary interlocking femoral nailing.
- The histology of the radiolucent line.
Schools
David Geffen School Of Medicine At UCLA University Of California Los Angeles
Harbor Ucla Mc
Massachusetts General Hospital
California Orthopaedic Association
Procedures Preformed
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Excision of Femur or Knee
- Excision of Tibula or Fibula
- Hip Fracture and-or Dislocation Treatment, Closed
- View All
Conditions Treated
- Ankylosing Spondylitis
- Arm Fracture (incl. Elbow and Shoulder)
- Back Pain
- Bakers Cyst
- View All
Doctors Specialties
- Orthopedic Surgery
- Orthopaedic Surgery
Accepted Insurances
Awards
- Fellow (FACS)
- Super Doctor
Education
-
Harbor - UCLA Medical Center -
David Geffen School of Medicine at UCLA
Hospital
-
Cedars-Sinai Medical Center -
Harbor-UCLA Medical Center
Drug Facts
| NPI NUMBER | 1750450276 | |
| NPPES Provider LastName | KWONG | |
| NPPES Provider FirstName | LOUIS | |
| NPPES Provider ZIPCode | 902105100 | |
| NPPES Provider State | CA | |
| Specialty Description | Orthopedic Surgery | |
| Total Claim Count | 28.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1750450276 |
| Last Name Of The Provider | KWONG |
| First Name Of The Provider | LOUIS |
| View All |
Similar Doctors
|
|
Dr. Seyed M. Rezaian, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Steven W. Meier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles R. Sadler Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric D. Schmitter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chester A. Hasday, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Taryn Rose, MD
This Doctor is OpenDoctor Recommended.
|